S'abonner

Impaired exercise capacity late after cardiac transplantation: Influence of chronotropic incompetence, hypertension, and calcium channel blockers - 09/09/11

Doi : 10.1016/S0002-8703(98)70221-2 
Rebecca Quigg, MD, Jeanne Salyer, RN, PhD, P.K. Mohanty, MD, Pippa Simpson, PhD
Chicago, Ill. and Richmond, Va. 

Abstract

Background and Methods Patients undergoing orthotopic cardiac transplantation manifest reduced exercise capacity during the first postoperative year, which is related primarily to chronotropic incompetence of the denervated heart. To determine whether exercise capacity improves during the long term after transplantation, we prospectively studied 45 patients from 1 month to 6 years after cardiac transplantation by use of maximal treadmill exercise testing for measurement of exercise duration, peak heart rate, and peak Vo2. All had normal left ventricular ejection fractions. Patients were categorized according to length of time since transplant and compared to 14 untrained normal subjects. Results Peak exercise heart rate and exercise duration were progressively higher as time after transplantation increased. However, patients who had undergone transplantation more than 2 years earlier continued to manifest a significant reduction in peak exercise heart rate (157 ± 3 beats/min vs 178 ± 14 beats/min) and reduced exercise duration (8.6 ± 0.5 minutes vs 13.2 ± 2.0 minutes) compared with controls. In contrast, peak Vo2 was similar at all times after transplant and remained markedly reduced in patients who underwent transplantation more than 2 years earlier as compared with controls (22.1 ± 0.7 mL/kg/min vs 42.1 ± 9.1 mL/kg/min). The potential effects of 14 clinical variables on exercise performance were evaluated by regression modeling. Patients with poorly controlled hypertension had a shorter median exercise duration (7.4 minutes vs 9.7 minutes) and a lower median peak Vo2 (20.3 mL/kg/min vs 23.2 mL/kg/min) compared with patients with normal or well-controlled blood pressure. Patients treated with calcium channel blockers for hypertension had greater chronotropic incompetence during exercise (peak heart rate 139 beats/min vs 158 beats/min). There was no relation between exercise capacity and recipient age, donor age, recipient sex, donor ischemic time, pretransplant diagnosis, length of peritransplant hospitalization, percentage of ideal body weight, left ventricular ejection fraction, frequency or severity of allograft rejection, or long-term use of oral prednisone therapy. Conclusions Exercise capacity, as measured by treadmill exercise time and peak heart rate, improves in the first 2 years after transplantation, but does not reach normal values in patients up to 6 years after transplant. Peak Vo2 remains significantly reduced at all times after transplantation despite the presence of normal resting left ventricular systolic function. (Am Heart J 1998;136:465-73.)

Le texte complet de cet article est disponible en PDF.

Plan


 From the Division of Cardiology, Northwestern University, and the Divisions of Cardiology and Biostatistics, Medical College of Virginia.
 Supported in part by the NIH Clinical Research Center Grant MO1 RROOO65.
 Reprint requests: Rebecca J. Quigg, MD, Director, Heart Failure/Cardiac Transplant Program, Northwestern University Medical School, 250 East Superior St., Suite 512, Chicago, IL 60611.
 4/1/90820


© 1998  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 136 - N° 3

P. 465-473 - septembre 1998 Retour au numéro
Article précédent Article précédent
  • Importance of intrinsic calf vasodilator capacity in determining distribution of skeletal muscle perfusion during supine bicycle exercise in patients with left ventricular dysfunction
  • Toshihiko Hattori, Tsutomu Sumimoto, Mutsuhito Kaida, Fumio Yuasa, Toshimitsu Jikuhara, Makoto Hikosaka, Tetsuro Sugiura, Toshiji Iwasaka
| Article suivant Article suivant
  • Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy
  • Nicos Spyrou, Jo Philpot, Rodney Foale, Paolo G. Camici, Francesco Muntoni

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.